Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Nemus Bioscience, Inc. (NMUS) Starts Presentation at Dawson James Conference

Nemus Bioscience, Inc. (OTC: NMUS) is a biopharmaceutical company with a focus on the discovery, development and commercialization of therapeutics based on naturally-derived or synthetically manufactured cannabis compounds. The company develops therapeutic products to treat glaucoma and other optic nerve-related disorders and conditions associated with muscle spasticity, epilepsy, anxiety, and methicillin-resistant staphylococcus aureus. Founded in 2012, the company is based in Costa Mesa, California. For more information, visit the company’s website at www.nemusbioscience.com

This entry was posted in Dawson James Conference. Bookmark the permalink.

Comments are closed.